Clinical Trial Update: Hydroxychloroquine Versus Placebo in COVID-19 Patients at Risk for Severe Disease [Phase 3]

View source ↗

Summary

A Phase 3 clinical trial comparing hydroxychloroquine to placebo in COVID-19 patients at risk for severe disease was terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Coronavirus Disease 2019

Drugs mentioned

• Hydroxychloroquine (hydroxychloroquine)

Snippet

Sponsor: University Hospital, Angers | Conditions: Coronavirus | Phase 3 | Status: TERMINATED